| 000 | 01785 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517185315.0 | ||
| 264 | 0 | _c20190312 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.14430 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, H | |
| 245 | 0 | 0 |
_aMarket share and costs of biologic therapies for inflammatory bowel disease in the USA. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c02 2018 |
||
| 300 |
_a364-370 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdministrative Claims, Healthcare _xstatistics & numerical data |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xeconomics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiological Products _xeconomics |
| 650 | 0 | 4 |
_aBiological Therapy _xeconomics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHealth Care Sector _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xeconomics |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xeconomics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aMacIsaac, D | |
| 700 | 1 | _aWong, J J | |
| 700 | 1 | _aSellers, Z M | |
| 700 | 1 | _aWren, A A | |
| 700 | 1 | _aBensen, R | |
| 700 | 1 | _aKin, C | |
| 700 | 1 | _aPark, K T | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 47 _gno. 3 _gp. 364-370 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.14430 _zAvailable from publisher's website |
| 999 |
_c27814588 _d27814588 |
||